Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis

Lotte Hiddingh; Rajiv S. Raktoe; Judith Jeuken; Esther Hulleman; David P. Noske; Gertjan J. L. Kaspers; W. Peter Vandertop; Pieter Wesseling; Thomas Wurdinger

doi:https://doi.org/10.1038/srep05260

Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis

Lotte Hiddingh, Rajiv S. Raktoe, Judith Jeuken, Esther Hulleman, David P. Noske, Gertjan J. L. Kaspers, W. Peter Vandertop, Pieter Wesseling, Thomas Wurdinger

Research output: Contribution to journal › Article › Academic › peer-review

31 Citations (Scopus)

Abstract

Drug resistance is a major issue in the treatment of glioblastoma. Almost all glioblastomas are intrinsically resistant to chemotherapeutic temozolomide (TMZ) or develop resistance during treatment. The interaction networks of microRNAs (miRNAs) and mRNAs likely regulate most biological processes and can be employed to better understand complex processes including drug resistance in cancer. In this study, we examined if integrative miRNA/mRNA network analysis using the web-service tool mirConnX could be used to identify drug resistance factors in glioblastoma. We used TMZ-resistant glioblastoma cells and their integrated miRNA/mRNA networks to identify TMZ-sensitizing factors. TMZ resistance was previously induced in glioblastoma cell lines U87, Hs683, and LNZ308. miRNA/mRNA expression profiling of these cells and integration of the profiles using mirConnX resulted in the identification of plant homeodomain (PHD)-like finger 6 (PHF6) as a potential TMZ-sensitizing factor in resistant glioblastoma cells. Analysis of PHF6 expression showed significant upregulation in glioblastoma as compared to normal tissue. Interference with PHF6 expression in three TMZ-resistant subclones significantly enhanced TMZ-induced cell kill in two of these cell lines. Altogether, these results demonstrate that mirConnX is a feasible and useful tool to investigate miRNA/mRNA interactions in TMZ-resistant cells and has potential to identify drug resistance factors in glioblastoma

Original language	English
Article number	5260
Pages (from-to)	5260
Journal	Scientific reports
Volume	4
DOIs	https://doi.org/10.1038/srep05260
Publication status	Published - 2014

Access to Document

https://doi.org/10.1038/srep05260

Cite this

@article{e2f25548cf234deaa1d8e9222d8fe967,

title = "Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis",

abstract = "Drug resistance is a major issue in the treatment of glioblastoma. Almost all glioblastomas are intrinsically resistant to chemotherapeutic temozolomide (TMZ) or develop resistance during treatment. The interaction networks of microRNAs (miRNAs) and mRNAs likely regulate most biological processes and can be employed to better understand complex processes including drug resistance in cancer. In this study, we examined if integrative miRNA/mRNA network analysis using the web-service tool mirConnX could be used to identify drug resistance factors in glioblastoma. We used TMZ-resistant glioblastoma cells and their integrated miRNA/mRNA networks to identify TMZ-sensitizing factors. TMZ resistance was previously induced in glioblastoma cell lines U87, Hs683, and LNZ308. miRNA/mRNA expression profiling of these cells and integration of the profiles using mirConnX resulted in the identification of plant homeodomain (PHD)-like finger 6 (PHF6) as a potential TMZ-sensitizing factor in resistant glioblastoma cells. Analysis of PHF6 expression showed significant upregulation in glioblastoma as compared to normal tissue. Interference with PHF6 expression in three TMZ-resistant subclones significantly enhanced TMZ-induced cell kill in two of these cell lines. Altogether, these results demonstrate that mirConnX is a feasible and useful tool to investigate miRNA/mRNA interactions in TMZ-resistant cells and has potential to identify drug resistance factors in glioblastoma",

author = "Lotte Hiddingh and Raktoe, {Rajiv S.} and Judith Jeuken and Esther Hulleman and Noske, {David P.} and Kaspers, {Gertjan J. L.} and Vandertop, {W. Peter} and Pieter Wesseling and Thomas Wurdinger",

year = "2014",

doi = "https://doi.org/10.1038/srep05260",

language = "English",

volume = "4",

pages = "5260",

journal = "Scientific reports",

issn = "2045-2322",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis

AU - Hiddingh, Lotte

AU - Raktoe, Rajiv S.

AU - Jeuken, Judith

AU - Hulleman, Esther

AU - Noske, David P.

AU - Kaspers, Gertjan J. L.

AU - Vandertop, W. Peter

AU - Wesseling, Pieter

AU - Wurdinger, Thomas

PY - 2014

Y1 - 2014

N2 - Drug resistance is a major issue in the treatment of glioblastoma. Almost all glioblastomas are intrinsically resistant to chemotherapeutic temozolomide (TMZ) or develop resistance during treatment. The interaction networks of microRNAs (miRNAs) and mRNAs likely regulate most biological processes and can be employed to better understand complex processes including drug resistance in cancer. In this study, we examined if integrative miRNA/mRNA network analysis using the web-service tool mirConnX could be used to identify drug resistance factors in glioblastoma. We used TMZ-resistant glioblastoma cells and their integrated miRNA/mRNA networks to identify TMZ-sensitizing factors. TMZ resistance was previously induced in glioblastoma cell lines U87, Hs683, and LNZ308. miRNA/mRNA expression profiling of these cells and integration of the profiles using mirConnX resulted in the identification of plant homeodomain (PHD)-like finger 6 (PHF6) as a potential TMZ-sensitizing factor in resistant glioblastoma cells. Analysis of PHF6 expression showed significant upregulation in glioblastoma as compared to normal tissue. Interference with PHF6 expression in three TMZ-resistant subclones significantly enhanced TMZ-induced cell kill in two of these cell lines. Altogether, these results demonstrate that mirConnX is a feasible and useful tool to investigate miRNA/mRNA interactions in TMZ-resistant cells and has potential to identify drug resistance factors in glioblastoma

AB - Drug resistance is a major issue in the treatment of glioblastoma. Almost all glioblastomas are intrinsically resistant to chemotherapeutic temozolomide (TMZ) or develop resistance during treatment. The interaction networks of microRNAs (miRNAs) and mRNAs likely regulate most biological processes and can be employed to better understand complex processes including drug resistance in cancer. In this study, we examined if integrative miRNA/mRNA network analysis using the web-service tool mirConnX could be used to identify drug resistance factors in glioblastoma. We used TMZ-resistant glioblastoma cells and their integrated miRNA/mRNA networks to identify TMZ-sensitizing factors. TMZ resistance was previously induced in glioblastoma cell lines U87, Hs683, and LNZ308. miRNA/mRNA expression profiling of these cells and integration of the profiles using mirConnX resulted in the identification of plant homeodomain (PHD)-like finger 6 (PHF6) as a potential TMZ-sensitizing factor in resistant glioblastoma cells. Analysis of PHF6 expression showed significant upregulation in glioblastoma as compared to normal tissue. Interference with PHF6 expression in three TMZ-resistant subclones significantly enhanced TMZ-induced cell kill in two of these cell lines. Altogether, these results demonstrate that mirConnX is a feasible and useful tool to investigate miRNA/mRNA interactions in TMZ-resistant cells and has potential to identify drug resistance factors in glioblastoma

U2 - https://doi.org/10.1038/srep05260

DO - https://doi.org/10.1038/srep05260

M3 - Article

C2 - 24919120

SN - 2045-2322

VL - 4

SP - 5260

JO - Scientific reports

JF - Scientific reports

M1 - 5260

ER -